Registered Kenya · PPB

METAMYCIN 0.5% EYE DROPS

CHLORAMPHENICAL 0.5% W/V

What it does

Chloramphenicol is an antibiotic used to treat bacterial infections.

Commonly used for: bacterial infections, eye infections (including conjunctivitis), typhoid fever

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
12464
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CHLORAMPHENICAL 0.5% W/V
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Dawa
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Baba Dogo Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:11:50 · updated 2026-07-20 08:55:18

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Chloramphenicol is an antibiotic used to treat bacterial infections.

What it treats

  • bacterial infections
  • eye infections (including conjunctivitis)
  • typhoid fever

How it works

It kills or stops the growth of bacteria by interfering with their ability to produce proteins.

Who it's for

It is used for people of all ages who have specific bacterial infections.

Cautions

  • • Can cause serious side effects, including blood disorders.
  • • Not recommended during pregnancy or breastfeeding without medical advice.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: chloramphenical

Chloramphenicol is a broad-spectrum antibiotic that is effective against a variety of Gram-positive and Gram-negative bacteria. It was originally derived from the bacterium Streptomyces venezuelae and is known for its ability to penetrate tissues and reach therapeutic concentrations in various body fluids, including the central nervous system. Chloramphenicol is primarily used in serious infections, especially those caused by organisms resistant to other antibiotics. Due to its potential to cause severe side effects, particularly bone marrow suppression, its use is often restricted to specific situations.

Indications

  • Bacterial meningitis
  • Typhoid fever
  • Severe rickettsial infections
  • Infections caused by anaerobic bacteria
  • Chlamydia infections
  • Bacterial conjunctivitis

Dosage

Children: Refer to

Adults: Refer to specific guidelines as doses can vary based on infection severity and patient response.

Mechanism of action

Chloramphenicol exerts its antibacterial effect by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, blocking the peptidyl transferase activity and preventing the formation of peptide bonds during protein synthesis. This action halts bacterial growth and replication, making chloramphenicol bacteriostatic.

Pharmacodynamics

The pharmacodynamics of chloramphenicol involve its ability to inhibit bacterial growth through the disruption of protein synthesis. Its bacteriostatic effect is particularly effective against a wide range of bacteria, including both aerobic and anaerobic organisms. The drug shows a time-dependent killing effect and has a significant post-antibiotic effect, meaning that its efficacy can continue even after serum levels have fallen below the minimum inhibitory concentration (MIC).

Pharmacokinetics

Chloramphenicol is well absorbed orally and can also be administered intravenously. It is widely distributed throughout the body, crossing the blood-brain barrier and reaching therapeutic levels in the central nervous system. The drug undergoes hepatic metabolism, with a considerable portion being conjugated to glucuronic acid. Its elimination half-life ranges from 1 to 3 hours in healthy adults, but can be prolonged in individuals with liver impairment or in newborns due to immature metabolic pathways. Renal excretion is a minor route of elimination, as most of the drug is metabolized.

Contra-indications

  • Hypersensitivity to chloramphenicol or any of its components
  • History of bone marrow suppression or aplastic anemia
  • Newborns and premature infants due to the risk of 'gray baby syndrome'

Adverse effects

  • Aplastic anemia
  • Bone marrow suppression
  • Gastrointestinal disturbances (nausea, vomiting, diarrhea)
  • Hypersensitivity reactions (rash, pruritus)
  • Peripheral neuropathy
  • Superinfection due to opportunistic pathogens

Interactions

  • May interact with drugs that affect bone marrow function
  • Caution with anticoagulants (risk of increased bleeding)
  • May enhance the effects of certain antidepressants
  • Potentially increases the effects of drugs metabolized by the liver

Precautions

  • Monitor blood counts during prolonged therapy
  • Use with caution in patients with liver disease
  • Assess renal function prior to use
  • Use during pregnancy only if clearly needed due to potential risks

Pregnancy

Chloramphenicol should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. It can cross the placenta and may pose risks such as fetal exposure leading to potential adverse effects.

Breast-feeding

Chloramphenicol is excreted in breast milk and may affect the nursing infant. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

  • Oral capsules
  • Oral suspension
  • Injection solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.